Hany Ariffin

14.2k total citations
111 papers, 2.4k citations indexed

About

Hany Ariffin is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Hematology. According to data from OpenAlex, Hany Ariffin has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Public Health, Environmental and Occupational Health, 38 papers in Molecular Biology and 34 papers in Hematology. Recurrent topics in Hany Ariffin's work include Acute Lymphoblastic Leukemia research (42 papers), Childhood Cancer Survivors' Quality of Life (22 papers) and Acute Myeloid Leukemia Research (16 papers). Hany Ariffin is often cited by papers focused on Acute Lymphoblastic Leukemia research (42 papers), Childhood Cancer Survivors' Quality of Life (22 papers) and Acute Myeloid Leukemia Research (16 papers). Hany Ariffin collaborates with scholars based in Malaysia, Singapore and United States. Hany Ariffin's co-authors include Allen Eng Juh Yeoh, Sameem Abdul Kareem, Shirley Kow Yin Kham, Thuan Chong Quah, Patrick Kelly, Nazneen Rahman, Sevgi Yetgin, Heidemarie Neitzel, Helmut Hanenberg and Francis P. Lach and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Hany Ariffin

107 papers receiving 2.3k citations

Peers

Countries citing papers authored by Hany Ariffin

Since Specialization

Citations

This map shows the geographic impact of Hany Ariffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hany Ariffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hany Ariffin more than expected).

Fields of papers citing papers by Hany Ariffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hany Ariffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hany Ariffin. The network helps show where Hany Ariffin may publish in the future.

Co-authorship network of co-authors of Hany Ariffin

This figure shows the co-authorship network connecting the top 25 collaborators of Hany Ariffin. A scholar is included among the top collaborators of Hany Ariffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hany Ariffin. Hany Ariffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation 2024 ·Clinical Transplantation ·Gin Gin Gan, Thevambiga Iyadorai, (unknown), (unknown), Hany Ariffin	0
2	Prognostic significance of molecular subgroups in survival outcome for children with medulloblastoma in Malaysia 2023 ·Frontiers in Oncology ·Revathi Rajagopal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hany Ariffin, David Jones, Éric Bouffet, Nicholas G. Gottardo	2
3	Manipulating the Gut Microbiome as a Therapeutic Strategy to Mitigate Late Effects in Childhood Cancer Survivors 2023 ·Technology in Cancer Research & Treatment ·(unknown), (unknown), (unknown), (unknown), Hany Ariffin	3
4	Anthracycline-Free Protocol for Favorable-Risk Childhood ALL: A Noninferiority Comparison Between Malaysia-Singapore ALL 2003 and ALL 2010 Studies 2023 ·Journal of Clinical Oncology ·Hany Ariffin, (unknown), (unknown), (unknown), (unknown), Shirley Kow Yin Kham, (unknown), Lee Lee Chan, Koon Mian Foo, Joyce Ching Mei Lam, Yiong Huak Chan, (unknown), Thuan Chong Quah, Ah Moy Tan, Allen Eng Juh Yeoh	5
5	Distinct clinical characteristics ofDUX4-andPAX5-altered childhood B-lymphoblastic leukemia 2021 ·Blood Advances ·Zhenhua Li, (unknown), (unknown), Yi Lü, Nan Jiang, (unknown), Elaine Coustan‐Smith, (unknown), (unknown), (unknown), Zhiwei Chen, Shirley Kow Yin Kham, Thuan Chong Quah, Hai Lin, Ah Moy Tan, Hany Ariffin, Jun J. Yang, Allen Eng Juh Yeoh	24
6	Practical Considerations for Using RNA Sequencing in Management of B-Lymphoblastic Leukemia 2021 ·Journal of Molecular Diagnostics ·(unknown), Zhenhua Li, Nan Jiang, (unknown), (unknown), Yi Lü, (unknown), Shirley Kow Yin Kham, (unknown), Ah Moy Tan, Hany Ariffin, Jun J. Yang, Allen Eng Juh Yeoh	6
7	Evolution of Hematopoietic Stem Cell Transplant Programs in Malaysia 2020 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Gin Gin Gan, (unknown), Hany Ariffin, (unknown), (unknown), (unknown), Ping Chong Bee	1
8	Malaysia-Singapore (MASPORE) leukaemia study group: From common history to successful collaboration 2020 ·SHILAP Revista de lepidopterología ·Hany Ariffin, (unknown), (unknown), (unknown), (unknown), Thuan Chong Quah, Allen Eng Juh Yeoh	5
9	RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia 2020 ·Oncogene ·(unknown), (unknown), Zhenhua Li, Emanuela Giarin, Jürgen Groet, (unknown), Shirley Kow‐Yin Kham, Wee Joo Chng, Hany Ariffin, David M. Weinstock, Allen Eng Juh Yeoh, Giuseppe Basso, Dean Nižetić	8
10	Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study 2018 ·Journal of Clinical Oncology ·Allen Eng Juh Yeoh, Yi Lü, (unknown), (unknown), (unknown), Zhenhua Li, Shirley Kow Yin Kham, Yiong Huak Chan, (unknown), Hai Lin, Lee Lee Chan, Joyce Ching Mei Lam, Poh Lin Tan, Thuan Chong Quah, Ah Moy Tan, Hany Ariffin	46
11	Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia 2016 ·Journal of Global Oncology ·Revathi Rajagopal, (unknown), Dharmendra Ganesan, (unknown), Kum Thong Wong, Norlisah Ramli, (unknown), Su Han Lum, (unknown), Éric Bouffet, Ibrahim Qaddoumi, Shekhar Krishnan, Hany Ariffin, (unknown)	19
12	Computer-aided acute leukemia blast cells segmentation in peripheral blood images 2015 ·Journal of Vibroengineering ·(unknown), Sameem Abdul Kareem, Hany Ariffin	14
13	Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia 2014 ·British Journal of Cancer ·Yi Lü, Shirley Kow Yin Kham, Hany Ariffin, Anneke Oei, (unknown), Ah Moy Tan, Thuan Chong Quah, Allen Eng Juh Yeoh	13
14	Minimal Residual Disease–Guided Treatment Deintensification for Children With Acute Lymphoblastic Leukemia: Results From the Malaysia-Singapore Acute Lymphoblastic Leukemia 2003 Study 2012 ·Journal of Clinical Oncology ·Allen Eng Juh Yeoh, Hany Ariffin, (unknown), (unknown), Yiong Huak Chan, Ponnudurai Kuperan, Dario Campana, Poh Lin Tan, Mei Yoke Chan, Shirley Kow Yin Kham, (unknown), Ah Moy Tan, Hai Lin, Thuan Chong Quah	86
15	Rapid detection of prognostically important childhood acute lymphoblastic leukemia chimeric transcripts using multiplex SYBR green real-time reverse transcription PCR. 2008 ·PubMed ·(unknown), (unknown), (unknown), Allen Eng Juh Yeoh, Hany Ariffin	4
16	Li–Fraumeni syndrome in a Malaysian kindred 2008 ·Cancer Genetics and Cytogenetics ·Hany Ariffin, Ghyslaine Martel‐Planche, (unknown), (unknown), Pierre Hainaut	8
17	Chemoreduction for Intraocular Retinoblastoma in Malaysia 2007 ·Journal of Pediatric Hematology/Oncology ·Bina Menon, (unknown), (unknown), (unknown), Hishamshah Mohd Ibrahim, (unknown), Hany Ariffin, Caroline Ho, (unknown), (unknown)	9
18	Cefepime monotherapy for treatment of febrile neutropenia in children 2006 ·Journal of Paediatrics and Child Health ·Hany Ariffin, (unknown), (unknown), (unknown)	17
19	Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli‐asparaginase or Erwinia‐asparaginase in childhood acute lymphoblastic leukemia (ALL) 2005 ·Pediatric Blood & Cancer ·(unknown), Shirley Kow Yin Kham, Hany Ariffin, Hai Lin, Thuan Chong Quah, Allen Eng Juh Yeoh	15
20	Haemophagocytic lymphohistiocytosis in Malaysian children 2005 ·Journal of Paediatrics and Child Health ·Hany Ariffin, Su Han Lum, (unknown), Karthik Shekhar, W A Ariffin, Ling Ling Chan, Hung‐Pin Lin	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact